Haemogram indices are as reliable as CURB-65 to assess 30-day mortality in Covid-19 pneumonia

Okan Bardakci1, Murat Das1, Gökhan Akdur1

  • 1Department of Emergency Medicine, Canakkale Onsekiz Mart University, 17020, Canakkale, Turkey.

Insights

Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) show similar accuracy to the CURB-65 score in predicting mortality for COVID-19 patients. These simple blood tests can aid emergency departments in quickly identifying high-risk individuals.

Area of Science:

  • Critical care medicine
  • Hematology
  • Infectious disease epidemiology

Background:

  • High mortality rates persist for COVID-19 and severe community-acquired pneumonia (CAP) despite advancements in critical care.
  • Accurate prediction of mortality is crucial for effective patient triage and management in emergency settings.

Observation:

  • This study retrospectively analyzed two cohorts: 324 COVID-19 patients and 257 CAP patients.
  • Non-survivors in the COVID-19 group exhibited significantly higher monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR).

Findings:

  • In multivariate analysis for COVID-19 patients, age and NLR were significant predictors of mortality.
  • A 1-unit increase in NLR was associated with a 5-7% increase in mortality probability.
  • Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) demonstrated reliability comparable to the CURB-65 score in predicting COVID-19 mortality.

Implications:

  • NLR and PLR can serve as accessible and reliable biomarkers for predicting mortality in COVID-19 pneumonia.
  • These ratios offer a valuable tool for emergency departments to rapidly triage and manage critically ill patients.
  • Integration of NLR and PLR into routine assessments could improve patient outcomes and resource allocation.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
338
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
254
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
277
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
23